Viewing Study NCT01789528

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-26 @ 11:13 AM
Ignite Modification Date: 2026-03-03 @ 11:50 PM
Study NCT ID: NCT01789528
Status: COMPLETED
Last Update Posted: 2017-09-05
First Post: 2013-02-04
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil -Avibactam (CXL) on the Intestinal Flora of Healthy Volunteers
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pharmacokinetics View
None Open Label View
None CAZ-AVI View
None CXL View
None Effect on Intestinal Flora View
None Safety View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Phase I, View
None open label, View
None CAZ-AVI, View
None CXL, View
None healthy volunteers, View
None intestinal flora. View